Bringing together researchers, patient advocates, clinicians, and supporters, the WORLDSymposium™ is dedicated to lysosomal disease research and the clinical investigation of the latest advances. Charles River is proud to participate in the scientific program with a presentation and several posters.
Visit us in booth 310 to learn about our commitment to rare diseases like Batten and the development of groundbreaking therapies, and discover how we can support your pursuit of treatment for lysosomal and other metabolic disorders.
Longitudinal characterization of the Cln8mnd-/- mouse model of CLN8 Batten disease fine motor performance, retinal degeneration, brain pathology, and metabolic changes | Kimmo Lehtimäki
|Behavioral and neurochemical abnormalities in a pharmacologically induced mouse model of the Gaucher disease | Julien Roeser|
|Principal component analysis (PCA) based data fusion approach for a mouse model of CLN8 Batten Disease | Juho Oksman|
For additional information on our conference participation or to schedule a meeting with our attending scientists, please email [email protected].